X-ray crystal structure details of compound 10a S43-45 General Information:
All reagents were commercial and were used without further purification.
Chromatography was carried on silica gel (60-120 and 100-200 mesh). 
Synthetic Procedures/Analytical Data of Compounds 10a-10x, 11 and 12:
Typical method for the preparation of 10a via MCR : The mixture of 2-carboxybenzaldehyde 7 (1.0 mmol), p-touledene 8a (1.0mmol) and 5,5-dimethylcyclohexane-1,3-dione 9b (1.0 mmol) in ethanol (1 mL) was allowed to one minute of pre-stirring followed by fifteen minutes of microwave irradiation at 90 °C. After completion of the reaction the mixture was filtered and dried to get product 10a as white solid.
In case of homogenous reaction mixtures, ethanol was removed in vacuo and resulting crude was purified by column chromatography (silica 100-200) in 2%
Methaol-DCM solvent system. 190.2, 183.6, 169.4, 148.0, 138.2, 135.4, 134.9, 133.1, 130.6, 129.0, 124.4, 123.8, 123.6, 111.1, 57.6, 49.2, 47.9, 33.2, 29.7, 28.6, 22.0 
3-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-enyl)-2-p-tolylisoindolin-1-one

A typical general procedure for synthesis of compound 10ab
A mixture of 3-(2-hydroxy-4, 4-dimethyl-6-oxocyclohex-1-enyl)-2-ptolylisoindolin-1-one (10a, 1.0 mmol), acetyl chloride (2.0 mmol) and triethylamine (3.0 mmol) in DCM was stirred at room temperature for 2.0 h.
S4
After completion of the reaction (monitored by TLC), the excess DCM was evaporated under reduced pressure and the residue was purified by column chromatography (CH 3 OH-DCM) to afford the compound 10ab. 197.7, 168.0, 167.3, 166.2, 144.0, 134.8, 134.7, 132.5, 132.2, 129.4, 128.2, 123.5, 122.9, 122.3, 122.1, 54.5, 50.4, 43.0, 32.8, 28.4, 26.6, 20.9, 20 169.3, 146.0, 135.7, 132.6, 132.0, 131.0, 128.9, 127.9, 124.4, 123.2, 122.2, 108.7, 56.7, 48.9, 44.8, 32.1, 28.8, 27.0 197.8, 169.3, 145.6, 141.8, 133.1, 132.8, 131.8, 129.2, 128.0, 123.3, 122.1, 121.6, 109.1, 56.1, 48.4, 45.2, 32.1, 28.6, 27 167.9, 155.7, 146.7, 134.2, 131.4, 130.8, 127.4, 124.8, 122.1, 115.8, 109.7, 56.6, 47.8, 46.8, 31.8, 28.4, 27 166.7, 146.8, 145.5, 143.8, 132.6, 132.1, 131.7, 127.4, 122.6, 121.7, 115.4, 108.3, 107.7, 104.1, 101.0, 55.6, 31.6, 28.3, 26 195.8, 178.7, 167.4, 146.6, 146.0, 134.0, 131.1, 130.1, 128.3, 126.6, 124.6, 124.4, 121.9, 121.7, 119.8, 110.6, 57.9, 50.6, 44.5, 30.6, 30 
3-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-enyl)-2-(thiazol-2-yl)isoindolin-
1-one(10m)
From 2-formyl benzoic acid, 2-amino thiozol and dimedone; white solid; yield: 166.4, 155.9, 146.1, 137.6, 133.2, 130.3, 128.0, 122.9, 122.3, 113.5, 56.3, 31.7, 28.4, 26.7 
3-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)-2-(prop-2-yn-1-yl)isoindolin-1-one(10p)
From 2-formyl benzoic acid, propargyl amine and dimedone; White solid; yield: 
3-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)-2-methylisoindolin-1-one(10q)
S10
From 2-formyl benzoic acid (1 mmol), 40% methyl amine solution (2.5 mmol) and dimedone (1 mmol 182.6, 168.7, 147.3, 134.0, 130.8, 127.1, 122.8, 122.0, 108.5, 56.5, 47.7, 46.9, 31.7, 28.0, 27.9, 27.0 
2-ethyl-3-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)isoindolin-1-one(10r)
From 2-formyl benzoic acid (1 mmol 188.3, 182.8, 168.3, 147.5, 134.2, 130.8, 127.1, 122.8, 122.0, 108.6, 54.2, 47.7, 46.9, 35.0, 31.7, 28.1, 27.8, 13.7 
3-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)-2-propylisoindolin-1-one(10s)
From 2-formyl benzoic acid, propyl amine and dimedone; white solid; yield: 188.6, 182.5, 168.7, 147.5, 134.1, 130.8, 127.1, 122.9, 122.1, 108.7, 54.6, 47.8, 46.8, 41.9, 31.8, 28.0, 27.9, 21.8, 11.5 170.0, 158.9, 146.8, 131.7, 129.4, 128.9, 127.4, 122.8, 121.9, 113.9, 107.9, 55.2, 49.0, 46.8, 44.2, 31.8, 28.7, 28.2, 27.8 δ 166.60, 144.34, 135.38, 133.37, 132.21, 132.11, 128.96, 128.00, 122.76, 122.34, 121.47, 111.20, 54.42, 20.48; HRMS (ESI) 8.26 (d, j = 4.7 Hz, 1H), 7.93 (d, j = 7.4 Hz, 1H), 1H), 1H), 1H), 1H), 1H) 196.4, 179.8, 168.5, 150.6, 145.8, 145.1, 139.9, 133.0, 131.8, 127.9, 124.0, 121.5, 119.3, 116.2, 112.1, 55.9, 37.0, 30.7, 19.7; HRMS (ESI) 195.5, 178.8, 168.5, 151.9, 150.4, 145.9, 144.5, 133.0, 131.9, 127.9, 124.1, 121.6, 120.7, 116.4, 110.8, 56.0, 50.5, 44.4, 30.9, 30.1, 26.5, 21.7 166.9, 164.8, 158.9, 152.6, 144.1, 135.0, 133.8, 133.0, 132.7, 131.9, 129.1, 128.1, 124.0, 122.9, 122.2, 121.6, 116.8, 116.3, 116.0, 99.7, 56.0, 20. To a mixture of 2-formyl benzoic acid (7, 1.0 mmol), and 2-amino thiophenol/ anthralimide in ethanol was added and allowed to one minute of pre-stirring followed by fifteen minutes of microwave irradiation at 90 °C. Figure 1 ORTEP diagram drawn with 30% ellipsoid probability for non-H atoms of the crystal structure of compound 10a determined at 293 K. Crystallization: Crystals of compound 10a were grown from the solvent pyridine by slow evaporation method.
X-Ray Data Collection and Structure Refinement Details:
A good quality single crystal of size 0.17 x 0.13 x 0.10 mm, was selected under a polarizing microscope and was mounted on a glass fiber for data collection. Single crystal Xray data for compound 10a were collected on the Rigaku Kappa 3 circle diffractometer equipped with the AFC12 goniometer and enhanced sensitivity (HG) Saturn724+ CCD detector in the 4x4 bin mode using the monochromated Mo-Kα radiation generated from the microfocus sealed tube MicroMax-003 X-ray generator equipped with specially designed confocal multilayer optics. Data collection was performed using ω-scans of 0.5 o steps at 293(2)K. Cell determination, data collection and data reduction were performed using the Rigaku Crystal Clear-SM Expert 2.1 b24 1 software. Structure solution and refinement were performed by using SHELX-97 2 . Refinement of coordinates and anisotropic thermal parameters of non-hydrogen atoms were carried out by the full-matrixleast-squares method. The hydrogen atoms attached to carbon atoms were generated with idealized geometries and isotropically refined using a riding model. 
